The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)

  • Konstantinos Stamatiou | stamatiouk@gmail.com Urology Department, Tzaneio Hospital, Piraeus, Greece.

Abstract

Aim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current clinical outcome measures in order to identify the most accurate.
Results: Current imaging outcome measures are consistent with clinical ones only in the group of patients with adenomatous- dominant BPH while are inconsistent in patients with small sized adenomas.
Conclusions: Additional studies and/or evaluation tools are needed in order to provide accurate evaluation of clinical success in the subgroup of patients with non- adenomatous-dominant BPH while they may inspire new options and novel techniques for both BPH treatment and treatment-follow up.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2018-03-31
Info
Issue
Section
Original Papers - Prostate
Keywords:
Benign prostatic hyperplasia, Lower urinary tract symptoms, Prostate artery embolization
Statistics
  • Abstract views: 938

  • PDF: 416
How to Cite
Stamatiou, K. (2018). The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH). Archivio Italiano Di Urologia E Andrologia, 90(1), 40-43. https://doi.org/10.4081/aiua.2018.1.40